Article Versions Notes

Ghasemi S, Naderi Saffar K, Ebrahimi F, Khatami P, Monazah A, Alizadeh G-A, Ettehadi H-A, Rad I, Nojehdehi S, Kehtari M, et al. Development of Inactivated FAKHRAVAC^® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models. Vaccines. 2021; 9(11):1271. https://doi.org/10.3390/vaccines9111271

Ghasemi, Soheil, Kosar Naderi Saffar, Firooz Ebrahimi, Pezhman Khatami, Arina Monazah, Ghorban-Ali Alizadeh, Hossein-Ali Ettehadi, Iman Rad, Shahrzad Nojehdehi, Mousa Kehtari, and et al. 2021. "Development of Inactivated FAKHRAVAC^® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models" Vaccines 9, no. 11: 1271. https://doi.org/10.3390/vaccines9111271

Ghasemi, S., Naderi Saffar, K., Ebrahimi, F., Khatami, P., Monazah, A., Alizadeh, G.-A., Ettehadi, H.-A., Rad, I., Nojehdehi, S., Kehtari, M., Kouhkan, F., Barjasteh, H., Moradi, S., Ghorbani, M.-H., Khodaeipour, A., Papizadeh, M., Najafi, R., Naghneh, E., Sadeghi, D., & Karimi Rahjerdi, A. (2021). Development of Inactivated FAKHRAVAC^® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models. Vaccines, 9(11), 1271. https://doi.org/10.3390/vaccines9111271